The higher risk of recurrence associated with posterior fossa location may be due to the increased prevalence of NF2 mutations in the posterior fossa (14, 15, 20), although we are unable to fully explore this as we do not routinely perform genetic testing of meningioma at our institution. Here, NF2 is linked to meningioma.